Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 18;25(6):1375.
doi: 10.3390/molecules25061375.

A Review on Applications of Computational Methods in Drug Screening and Design

Affiliations
Review

A Review on Applications of Computational Methods in Drug Screening and Design

Xiaoqian Lin et al. Molecules. .

Abstract

Drug development is one of the most significant processes in the pharmaceutical industry. Various computational methods have dramatically reduced the time and cost of drug discovery. In this review, we firstly discussed roles of multiscale biomolecular simulations in identifying drug binding sites on the target macromolecule and elucidating drug action mechanisms. Then, virtual screening methods (e.g., molecular docking, pharmacophore modeling, and QSAR) as well as structure- and ligand-based classical/de novo drug design were introduced and discussed. Last, we explored the development of machine learning methods and their applications in aforementioned computational methods to speed up the drug discovery process. Also, several application examples of combining various methods was discussed. A combination of different methods to jointly solve the tough problem at different scales and dimensions will be an inevitable trend in drug screening and design.

Keywords: de novo design; machine learning; multiscale models; virtual screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Yamanishi Y., Araki M., Gutteridge A., Honda W., Kanehisa M. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces. Bioinformatics. 2008;24:i232–i240. doi: 10.1093/bioinformatics/btn162. - DOI - PMC - PubMed
    1. Bakheet T.M., Doig A.J. Properties and identification of human protein drug targets. Bioinformatics. 2009;25:451–457. doi: 10.1093/bioinformatics/btp002. - DOI - PubMed
    1. Moult J., Fidelis K., Kryshtafovych A., Schwede T., Tramontano A. Critical assessment of methods of protein structure prediction (CASP)—Round XII. Proteins Struct. Funct. Bioinf. 2018;86:7–15. doi: 10.1002/prot.25415. - DOI - PMC - PubMed
    1. Ayton G.S., Noid W.G., Voth G.A. Multiscale modeling of biomolecular systems: In serial and in parallel. Curr. Opin. Struct. Biol. 2007;17:192–198. doi: 10.1016/j.sbi.2007.03.004. - DOI - PubMed
    1. Shoichet B.K. Virtual screening of chemical libraries. Nature. 2004;432:862–865. doi: 10.1038/nature03197. - DOI - PMC - PubMed

LinkOut - more resources